Continuing Education

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the American Association for Cancer Education.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Amedco LLC designates this live and enduring material for a maximum of 21.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses
Amedco LLC designates this activity for a maximum of 21.00 ANCC contact hours.

CHES/MCHES
This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 21.00 total Category I continuing education contact hours. Maximum advanced-level CECH available are 21.00.
Advanced-level contact hours earned Provider ID # 98001.
Program number is 36711.


AACE has a pending application for Social Worker accreditation with NASW.
 
The International Cancer Education Conference explores new and creative education models that support the development of best practices and facilitates interdisciplinary research across the cancer care continuum.

Jointly Provided By:

Amedco LLC and the American Association for Cancer Education



AACE

 

 

Disclaimers
The information provided at this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Commercial Support
Commercial Support in the form of Independent Medical Education Grants is being sought for this activity. All fully executed grants will be disclosed at the activity.

Equal Opportunity and ADA
Amedco LLC is an Equal Opportunity / Affirmative Action / Equal Access Institution.

Target Audience

Oncologists, primary care physicians, surgeons, radiologists, ministries of health, cancer experts (government and association), researchers, nurses, dentists, geneticists, epidemiologists, behavioral scientists, pharmacists, pharmacologists, health educators, librarians, social workers, allied and public health professionals, students, and patient advocacy groups will be in attendance. Past participants have included attendees from the world’s medical centers, cancer care organizations, and academic institutions responsible for developing, implementing, and evaluating cancer education curricula, research, and programs.

Learning Objectives

After attending this conference, the participant shall be able to:

Healthcare Professional Education

  • Develop strategies that explore and address social determinants of health to alleviate cancer disparities.
  • Identify and support training, interdisciplinary collaboration, and mentorship opportunities for junior investigators and practitioners to support their development as cancer researchers and educators.
  • Plan and advocate for interdisciplinary programs that promote patient-centered care and equity in diagnosis, prevention, treatment, and survivorship of cancer for patients, their families, communities, and society.

Patient, Family, and Public Education

  • Identify and implement innovative and evidence-based cancer education strategies, including culturally, linguistically, and literacy relevant approaches.
  • Discuss creative and effective approaches to incorporating multimedia and technology in cancer education, including in the design, implementation, and evaluation of programs.
  • Promote best practices of patient-centered care to improve social, economic and environmental conditions, promote health equity and engage and educate patients, families, and survivors.
  • Discuss new technologies in genetics, genomics, and precision medicine across the continuum of cancer care (from prevention to survivorship).

Global Outreach

  • Enhance collaborations to enable participants across the care continuum to foster new discoveries and lead to lowering the global burden of cancer.
  • Identify opportunities to support and promote biomedical, clinical, behavioral, and health services research that is culturally competent and responsive to the needs of underserved populations.
  • Support activities that establish and promote global cancer education initiatives among national and international cancer education organizations.